Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renaissance BioScience develops and commercializes innovative yeast-based biotechnology solutions primarily targeting food safety, beverage quality, crop protection, plant protein flavor improvement, and animal health. Their products include commercially available yeast strains that reduce acrylamide formation in foods and hydrogen sulfide in alcoholic beverages. The company has also developed proprietary technologies for RNA production/delivery with potential applications across agriculture and animal health. They have received industry recognition for their crop protection innovations and maintain active partnerships with academic organizations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio Renaissance.